Streetbeat News

Stock Prices

DKS

Analyst ratings for Dick's Sporting Goods (NYSE:DKS) show diverse perspectives, with recent updates indicating a positive shift in sentiment. The average 12-month price target has risen to $217.17, reflecting a 30.32% increase from the previous target. Analysts from firms like Jefferies, Oppenheimer, and UBS have adjusted their ratings and price targets, generally raising their expectations for DKS's stock performance. The company's financial health is strong, with a market capitalization above industry average, a revenue growth rate of 7.77%, and superior net margin, ROE, and ROA compared to industry averages.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 2:01 pm

ZS

Zscaler (NASDAQ:ZS) has significantly outperformed the market with an annualized return of 22.4% over the past 5 years, turning a $1000 investment into $2,715.54. The company now has a market capitalization of $27.28 billion.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 2:00 pm

FN

Over the past 10 years, Fabrinet (NYSE:FN) has delivered an average annual return of 23.46%, outperforming the market by 12.75% on an annualized basis. With a current market capitalization of $6.30 billion, an initial investment of $1000 in FN stock would have grown to $8,379.34 today.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 2:00 pm

SPY

The Michigan Consumer Sentiment Index for April came in at 77.9, below the estimated 79.0 and the previous month's 79.4, indicating a slight decline in consumer confidence.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 2:00 pm

AFCG

IIPR

MSOS

NLCP

REFI

SSIC

Chicago Atlantic Real Estate Finance (NASDAQ:REFI) is highlighted for its growth and resilience in the cannabis sector, with a bullish Overweight rating from Zuanic & Associates. The report compares REFI favorably against AFC Gamma (NASDAQ:AFCG), noting its superior loan portfolio performance and lower non-accruals. REFI's dividend is expected to increase, and its stock has shown an 11% year-on-year growth. The analysis also mentions other significant stocks in the sector, including MSOS (ETF: MSOS), IIPR (NYSE:IIPR), NLCP (OTC:NLCP), and SSIC (NASDAQ:SSIC), each offering unique investment opportunities in the cannabis market.

Portfolio Pulse from Nicolás Jose Rodriguez

April 12, 2024 | 2:00 pm

USO

VGK

Russian oil and products are currently stranded on four tankers due to new Iran-related sanctions, according to Reuters citing LSEG data. This development could impact the global oil supply chain and market dynamics, potentially affecting related stocks and ETFs.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 1:58 pm

RANI

Rani Therapeutics Holdings saw a notable options activity with a sweep of 143 calls for April 19 at a $2.5 strike price near the ask, against an open interest of 765. This activity comes ahead of their estimated earnings report on May 8, after market close, with the reference stock price at $5.12.

Portfolio Pulse from Charles Gross

April 12, 2024 | 1:58 pm

PR

JP Morgan analyst Arun Jayaram maintains an Overweight rating on Permian Resources (NYSE:PR) and raises the price target from $18 to $20.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 1:48 pm

BLK

SPY

On CNBC, BlackRock CEO Larry Fink discussed projections of 2 rate cuts this year, indicating potential shifts in monetary policy that could impact financial markets.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 1:46 pm

BTCUSD

MSTR

Bitcoin (CRYPTO: BTC) is showing signs of a significant price movement, potentially reaching $100,000, as its correlation with traditional stock markets diminishes, according to market intelligence firm Santiment. This divergence was highlighted following new inflation data, with Bitcoin demonstrating resilience by bouncing back above $70,000. The potential inclusion of MicroStrategy Inc. (NASDAQ: MSTR), the largest corporate holder of Bitcoin, into the S&P 500 could further integrate Bitcoin into mainstream investment portfolios.

Portfolio Pulse from Benzinga Neuro

April 12, 2024 | 1:46 pm